NovaSeq X plus Sequencing System

The NGS genomics laboratory is planning to replace its high output sequencing instrument. The Illumina Novaseq X plus is a unique instrument and currently the only instrument on the market which meets all the specific and necessary technical requirements specified below to fulfill the uncompromising needs of the acquiring unit. …

CPV: 33124000 Diagnostics and radiodiagnostic devices and supplies
Place of execution:
NovaSeq X plus Sequencing System
Awarding body:
University of Helsinki
Award number:
537437

1. Buyer

1.1 Buyer

Official name : University of Helsinki
Legal type of the buyer : Body governed by public law

2. Procedure

2.1 Procedure

Title : NovaSeq X plus Sequencing System
Description : The NGS genomics laboratory is planning to replace its high output sequencing instrument. The Illumina Novaseq X plus is a unique instrument and currently the only instrument on the market which meets all the specific and necessary technical requirements specified below to fulfill the uncompromising needs of the acquiring unit. The specific requirements for the new instrument are: • Capacity and throughput of at least 16 Tb in about 2 days. • Read length of at least 2x150bp. • Multiplexing of tens to thousands of samples from different applications in one run. • Availability of flow cells with different capacity, which allows running e.g. few to dozens human genomes in a single run. • Possibility to run multiple applications simultaneously in a flow cell. • Capacity of up to 50 billion reads per run • On-instrument data processing to FASTQ and ability to do primary analysis of data (mapping to genome). • On instrument data processing for multiple application types from same sequencing run. • Runs on the instrument can be fully automated to include clustering, sequencing and secondary analysis. • Small instrument footprint in laboratory premises (WxDxH 90 cm x 95 cm x 170 cm). • Reagents can be shipped in room temperature allowing more sustainable shipments. • Suitable for analysis of genomes, exomes, transcriptomes, and epigenomes of organisms with large genomes. • Separate server that is compatible with the on-instrument server and suitable for re-analyses and further analyses of the data with the same pipelines as in the on-instrument server. • Compatible with the existing infrastructure, including supporting instrumentation, sample preparation and quality control system.
Procedure identifier : 31509ca5-5794-44cc-8235-f7b4ad4fae79
Internal identifier : 537437
Type of procedure : Negotiated without prior call for competition

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33124000 Diagnostics and radiodiagnostic devices and supplies

2.1.2 Place of performance

Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland

2.1.4 General information

Legal basis :
Directive 2014/24/EU

5. Lot

5.1 Lot technical ID : LOT-0000

Title : NovaSeq X plus Sequencing System
Description : The NGS genomics laboratory is planning to replace its high output sequencing instrument. The Illumina Novaseq X plus is a unique instrument and currently the only instrument on the market which meets all the specific and necessary technical requirements specified below to fulfill the uncompromising needs of the acquiring unit. The specific requirements for the new instrument are: • Capacity and throughput of at least 16 Tb in about 2 days. • Read length of at least 2x150bp. • Multiplexing of tens to thousands of samples from different applications in one run. • Availability of flow cells with different capacity, which allows running e.g. few to dozens human genomes in a single run. • Possibility to run multiple applications simultaneously in a flow cell. • Capacity of up to 50 billion reads per run • On-instrument data processing to FASTQ and ability to do primary analysis of data (mapping to genome). • On instrument data processing for multiple application types from same sequencing run. • Runs on the instrument can be fully automated to include clustering, sequencing and secondary analysis. • Small instrument footprint in laboratory premises (WxDxH 90 cm x 95 cm x 170 cm). • Reagents can be shipped in room temperature allowing more sustainable shipments. • Suitable for analysis of genomes, exomes, transcriptomes, and epigenomes of organisms with large genomes. • Separate server that is compatible with the on-instrument server and suitable for re-analyses and further analyses of the data with the same pipelines as in the on-instrument server. • Compatible with the existing infrastructure, including supporting instrumentation, sample preparation and quality control system.
Internal identifier : 778312

5.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33124000 Diagnostics and radiodiagnostic devices and supplies

5.1.2 Place of performance

Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Additional information :

5.1.3 Estimated duration

Other duration : Unlimited

5.1.6 General information

Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA) : yes

5.1.10 Award criteria

Criterion :
Type : Quality
Name :
Description : Quality criteria for direct procurement
Order of importance : 1
Description of the method to be used if weighting cannot be expressed by criteria :
Justification for not indicating the weighting of the award criteria : direct procurement

5.1.16 Further information, mediation and review

Review organisation : Markkinaoikeus
TED eSender : Hansel Oy (Hilma)

6. Results

Value of all contracts awarded in this notice : 1 062 496,6 Euro
Direct award :
Justification for direct award : The contract can be provided only by a particular economic operator because of an absence of competition for technical reasons
Other justification : The NGS genomics laboratory is planning to replace its high output sequencing instrument. The Illumina Novaseq X plus is a unique instrument and currently the only instrument on the market which meets all the specific and necessary technical requirements specified below to fulfil the uncompromising needs of the acquiring unit. The specific requirements for the new instrument are: • Capacity and throughput of at least 16 Tb in about 2 days. • Read length of at least 2x150bp. • Multiplexing of tens to thousands of samples from different applications in one run. • Availability of flow cells with different capacity, which allows running e.g. few to dozens human genomes in a single run. • Possibility to run multiple applications simultaneously in a flow cell. • Capacity of up to 50 billion reads per run • On-instrument data processing to FASTQ and ability to do primary analysis of data (mapping to genome). • On instrument data processing for multiple application types from same sequencing run. • Runs on the instrument can be fully automated to include clustering, sequencing and secondary analysis. • Small instrument footprint in laboratory premises (WxDxH 90 cm x 95 cm x 170 cm). • Reagents can be shipped in room temperature allowing more sustainable shipments. • Suitable for analysis of genomes, exomes, transcriptomes, and epigenomes of organisms with large genomes. • Separate server that is compatible with the on-instrument server and suitable for re-analyses and further analyses of the data with the same pipelines as in the on-instrument server. • Compatible with the existing infrastructure, including supporting instrumentation, sample preparation and quality control system.

6.1 Result lot ldentifier : LOT-0000

6.1.2 Information about winners

Winner :
Official name : Illumina Finland Oy
Tender :
Tender identifier : Illumina's tender
Identifier of lot or group of lots : LOT-0000
Contract information :
Identifier of the contract : Agreement with Illumina
Date on which the winner was chosen : 27/11/2024
The contract is awarded within a framework agreement : no

8. Organisations

8.1 ORG-0001

Official name : University of Helsinki
Registration number : 0313471-7
Postal address : Fabianinkatu 33
Town : Helsinki
Postcode : 00100
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : Hankinnat
Telephone : +358 294150719
Internet address : https://www.helsinki.fi/en
Roles of this organisation :
Buyer

8.1 ORG-0002

Official name : Markkinaoikeus
Registration number : 3006157-6
Postal address : Radanrakentajantie 5
Town : Helsinki
Postcode : 00520
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : +358 295643300
Roles of this organisation :
Review organisation

8.1 ORG-0003

Official name : Illumina Finland Oy
Registration number : 2837735-2
Town : Helsinki
Postcode : 00180
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : +358 50 4628259
Roles of this organisation :
Tenderer
Winner of these lots : LOT-0000

8.1 ORG-0004

Official name : Hansel Oy (Hilma)
Registration number : FI09880841
Postal address : Mannerheiminaukio 1a
Town : Helsinki
Postcode : 00100
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : eSender
Telephone : 029 55 636 30
Roles of this organisation :
TED eSender

11. Notice information

11.1 Notice information

Notice identifier/version : e65253c1-7fab-441e-b31e-f40c31663bfb - 01
Form type : Direct award preannouncement
Notice type : Voluntary ex-ante transparency notice
Notice dispatch date : 02/12/2024 13:07 +00:00
Notice dispatch date (eSender) : 02/12/2024 13:08 +00:00
Languages in which this notice is officially available : English

11.2 Publication information

Notice publication number : 00736639-2024
OJ S issue number : 235/2024
Publication date : 03/12/2024